Associated Papers
Unrecognised actionability for breast cancer risk variants identified in a national-level review of Australian familial cancer centres.
Fortuno C et al.
European Journal of Human Genetics : Ejhg, 2024
Ethnic-specificity, evolution origin and deleteriousness of Asian BRCA variation revealed by over 7500 BRCA variants derived from Asian population.
Qin Z et al.
International Journal of Cancer, 2023
BRCA1 and BRCA2 Variation in Taiwanese General Population and the Cancer Cohort.
Chian J et al.
Frontiers in Molecular Biosciences, 2021
Classification of variants of uncertain significance in BRCA1 and BRCA2 using personal and family history of cancer from individuals in a large hereditary cancer multigene panel testing cohort.
Li H et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2020
Germline variation in BRCA1/2 is highly ethnic-specific: Evidence from over 30,000 Chinese hereditary breast and ovarian cancer patients.
Bhaskaran SP et al.
International Journal of Cancer, 2019
Identification of a Novel BRCA1 Pathogenic Mutation in Korean Patients Following Reclassification of BRCA1 and BRCA2 Variants According to the ACMG Standards and Guidelines Using Relevant Ethnic Controls.
Park JS et al.
Cancer Research and Treatment, 2017
Monoallelic characteristic-bearing heterozygous L1053X in BRCA2 gene among Sudanese women with breast cancer.
Elimam AA et al.
Bmc Medical Genetics, 2017
Mutational spectrum in breast cancer associated BRCA1 and BRCA2 genes in Colombia.
Briceño-Balcázar I et al.
Colombia Medica (cali, Colombia), 2017
Single nucleotide polymorphisms in the mitochondrial displacement loop and age-at-onset of familial breast cancer.
Lee H et al.
Mitochondrial Dna. Part A, Dna Mapping, Sequencing, and Analysis, 2016
Prevalence and spectrum of BRCA germline variants in mainland Chinese familial breast and ovarian cancer patients.
Kim YC et al.
Oncotarget, 2016
Benchmarking mutation effect prediction algorithms using functionally validated cancer-related missense mutations.
Martelotto LG et al.
Genome Biology, 2014
Establishment and characterization of two primary breast cancer cell lines from young Indian breast cancer patients: mutation analysis.
Pandrangi SL et al.
Cancer Cell International, 2014
BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation.
Stordal B et al.
Molecular Oncology, 2013
A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.
Karami F et al.
Biomed Research International, 2013
Prevalance of BRCA1 and BRCA2 mutations in familial breast cancer patients in Lebanon.
Jalkh N et al.
Hereditary Cancer in Clinical Practice, 2012
BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: novel mutations and unclassified variants.
Tazzite A et al.
Gynecologic Oncology, 2012
A high-throughput protocol for mutation scanning of the BRCA1 and BRCA2 genes.
Hondow HL et al.
Bmc Cancer, 2011
The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population.
Stegel V et al.
Bmc Medical Genetics, 2011
Novel germline mutations in BRCA2 gene among breast and breast-ovarian cancer families from Poland.
Balabas A et al.
Familial Cancer, 2010
No evidence of BRCA2 mutations in chromosome 13q-linked Utah high-risk prostate cancer pedigrees.
Allen-Brady K et al.
Bmc Research Notes, 2009
Germ-line DNA polymorphisms and susceptibility to differentiated thyroid cancer.
Adjadj E et al.
The Lancet. Oncology, 2009
Mouse embryonic stem cell-based functional assay to evaluate mutations in BRCA2.
Kuznetsov SG et al.
Nature Medicine, 2008
BRCA2 mutations as a universal risk factor for pancreatic cancer has a limited role in Korean ethnic group.
Cho JH et al.
Pancreas, 2008
BRCA1 and BRCA2 germline mutations in Malaysian women with early-onset breast cancer without a family history.
Toh GT et al.
Plos One, 2008
Common variants of DNA repair genes and malignant melanoma.
Debniak T et al.
European Journal of Cancer (oxford, England : 1990), 2008
Contribution of BRCA1 and BRCA2 germline mutations to the incidence of early-onset breast cancer in Cyprus.
Loizidou M et al.
Clinical Genetics, 2007
Mutation analysis of BRCA1 and BRCA2 from 793 Korean patients with sporadic breast cancer.
Han SH et al.
Clinical Genetics, 2006
Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.
Giannini G et al.
Breast Cancer Research and Treatment, 2006
Identification of BRCA1 and BRCA2 mutations from Korean breast cancer patients using denaturing HPLC.
Kim BY et al.
Biochemical and Biophysical Research Communications, 2006
[Prevalence of Val158Met polymorphism in COMT gene on non-BRCA1/2 hereditary breast cancer].
Song CG et al.
Zhonghua Wai Ke Za Zhi [chinese Journal of Surgery], 2006
The prevalence of BRCA1 and BRCA2 mutations in eastern Chinese women with breast cancer.
Song CG et al.
Journal of Cancer Research and Clinical Oncology, 2006
Screening for RAD51 and BRCA2 BRC repeat mutations in breast and ovarian cancer families.
Rapakko K et al.
Cancer Letters, 2006
[BRCA1 and BRCA2 gene mutations of familial breast cancer from Shanghai in China].
Song CG et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics, 2006
Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.
Gallardo M et al.
Breast Cancer Research and Treatment, 2006
Radiation response genotype and risk of differentiated thyroid cancer: a case-control analysis.
Sturgis EM et al.
The Laryngoscope, 2005
Prevalence and clinical correlations of BRCA1/BRCA2 unclassified variant carriers among unselected primary ovarian cancer cases - preliminary report.
Majdak EJ et al.
European Journal of Cancer (oxford, England : 1990), 2005
BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer.
Seo JH et al.
Human Mutation, 2004
Familial breast and ovarian cancers.
Arai M et al.
International Journal of Clinical Oncology, 2004
[Germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in China Han people].
Zhou YZ et al.
Zhonghua Yi Xue Za Zhi, 2004
Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects.
Díez O et al.
Human Mutation, 2003
BRCA2 germline mutations in Cypriot patients with familial breast/ovarian cancer.
Hadjisavvas A et al.
Human Mutation, 2003
Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene.
Edwards SM et al.
American Journal of Human Genetics, 2003
Identification of specific BRCA1 and BRCA2 variants by DHPLC.
Gross E et al.
Human Mutation, 2000
BRCA2 germline mutations in Japanese breast cancer families.
Inoue R et al.
International Journal of Cancer, 1997
[Breast cancer genetics. BRCA1 and BRCA2: the main genes for disease predisposition].
Ruiz-Flores P et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion, 0
Clinical follow up of mexican women with early onset of breast cancer and mutations in the BRCA1 and BRCA2 genes.
Calderón-Garcidueñas AL et al.
Salud Publica De Mexico, 0
Germline and Somatic mutations in postmenopausal breast cancer patients.
Nagy TR et al.
Clinics (sao Paulo, Brazil), 0